Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

checkorphan
Learn more about:
Tuberculous meningitis
Related Clinical Trial
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial) The Relationships Between Gene Polymorphisms of LTA4H and Dexamethasone Treatment for Tuberculous Meningitis Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis

Brief Title

Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

Official Title

Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

Brief Summary

      All patients who were alive at the end of the dexamethasone treatment trial conducted by
      Oxford University CLinical Research Unit from 2001-2005 (n=340) will be eligible to
      participate in this long-term follow-up study.

      All eligible and consenting patients will undergo an assesment consisting of a simple
      questionnaire, a clinical examination and a blood test. Data collected will focus on
      survival, neurological disability and tuberculosis relapse. Data will be collected in
      individual case record forms and entered into a computer database.

Study Type

Observational

Primary Outcome

Survival

Secondary Outcome

 Neurological disability

Condition

Tuberculosis Meningitis

Intervention

Observation

Study Arms / Comparison Groups

 Survivors of TBM trial 2001-2005
Description:

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Other

Estimated Enrollment

340

Start Date

April 2006

Completion Date

April 2008

Primary Completion Date

April 2008

Eligibility Criteria

        Inclusion Criteria:Patients were alive at the end of the dexamethasone study (n=340) will
        be eligible to participate in this long-term follow-up study Informed consent

        Exclusion Criteria:

        Patients without informed consent

Gender

All

Ages

1 Year - 90 Years

Accepts Healthy Volunteers

No

Contacts

Estee Torok, MD, ,

Administrative Informations

NCT ID

NCT01317654

Organization ID

ES

Responsible Party

Sponsor

Study Sponsor

Oxford University Clinical Research Unit, Vietnam

Collaborators

 Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Study Sponsor

Estee Torok, MD, Principal Investigator, Oxford University Clinical Research Unit - Viet Nam

Verification Date

September 2011